{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T11:51:12Z","timestamp":1778413872196,"version":"3.51.4"},"reference-count":24,"publisher":"Medknow","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["smedj"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.11622\/smedj.2018078","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T06:56:33Z","timestamp":1529564193000},"page":"34-39","source":"Crossref","is-referenced-by-count":14,"title":["Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations"],"prefix":"10.4103","volume":"60","author":[{"given":"BYM","family":"Soh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VSM","family":"Ekstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CYH","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Thangaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HH","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KP","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LHL","family":"Choong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WC","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","published-online":{"date-parts":[[2019,1]]},"reference":[{"key":"ref0","unstructured":"1. World Health Organization. Hepatitis C. Fact sheet. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/. Accessed July 1, 2016."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","unstructured":"2. Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 2013; 10:553-62.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013","volume":"388","author":"Stanaway","year":"2016","unstructured":"3. Stanaway JD, Flaxman AD, Naghavi M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 2016; 388:1081-8.","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.drugpo.2007.04.004","article-title":"Global estimates of prevalence of HCV infection among injecting drug users","volume":"18","author":"Aceijas","year":"2007","unstructured":"4. Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007; 18:352-8.","journal-title":"Int J Drug Policy"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1053\/gast.2002.33428","article-title":"Molecular diagnosis of viral hepatitis","volume":"122","author":"Pawlotsky","year":"2002","unstructured":"5. Pawlotsky JM. Molecular diagnosis of viral hepatitis. Gastroenterology 2002; 122:1554-68.","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","unstructured":"6. Messina JP, Humphreys I, Flaxman A, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 2015; 61:77-87.","journal-title":"Hepatology"},{"key":"ref6","first-page":"387","article-title":"A study on the epidemiology of hepatitis C infection among blood donors in Singapore.","volume":"17","author":"Wang","year":"1995","unstructured":"7. Wang JE. A study on the epidemiology of hepatitis C infection among blood donors in Singapore. J Public Health Med 1995; 17:387-91.","journal-title":"J Public Health Med","ISSN":"https:\/\/id.crossref.org\/issn\/0957-4832","issn-type":"print"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","unstructured":"8. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461:399-401.","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.7150\/ijms.3.41","article-title":"Epidemiology of hepatitis C virus (HCV) infection","volume":"3","author":"Sy","year":"2006","unstructured":"9. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3:41-6.","journal-title":"Int J Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3904\/kjim.2015.30.4.423","article-title":"A 2015 roadmap for the management of hepatitis C virus infections in Asia","volume":"30","author":"SG","year":"2015","unstructured":"10. Lim SG, Dan YY. A 2015 roadmap for the management of hepatitis C virus infections in Asia. Korean J Intern Med 2015; 30:423-33.","journal-title":"Korean J Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","unstructured":"11. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57:1333-42.","journal-title":"Hepatology"},{"key":"ref11","first-page":"127","article-title":"Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore.","volume":"24","author":"Kuperan","year":"1993","unstructured":"12. Kuperan P, Choon AT, Ding SH, Lee G. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore. Southeast Asian J Trop Med Public Health 1993; 24 Suppl 1:127-9.","journal-title":"Southeast Asian J Trop Med Public Health","ISSN":"https:\/\/id.crossref.org\/issn\/0125-1562","issn-type":"print"},{"issue":"109","key":"ref12","first-page":"S1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease.","year":"2008","unstructured":"13. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl 2008; (109):S1-99.","journal-title":"Kidney Int Suppl","ISSN":"https:\/\/id.crossref.org\/issn\/0098-6577","issn-type":"print"},{"key":"ref13","unstructured":"5. 21st report of the Malaysian Dialysis and Transplant Registry 2013. Available at: https:\/\/www.crc.gov.my\/wp-content\/uploads\/documents\/report\/21stdialysis_transplant_2013.pdf. Accessed September 1, 2016."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ki.1997.139","article-title":"Hepatitis C virus infection in dialysis and renal transplantation","volume":"51","author":"BJ","year":"1997","unstructured":"15. Pereira BJ, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997; 51:981-99.","journal-title":"Kidney Int"},{"key":"ref15","unstructured":"6. Ministry of Health, Singapore. Singapore Renal Registry Report No. 10. Trends in chronic kidney failure stage 5 in Singapore 2012\/2013. Available at: https:\/\/www.nrdo.gov.sg\/docs\/librariesprovider3\/default-document-library\/trends-in-chronic-kidney-failure-in-singapore-2012-2013-web.pdf?sfvrsn=0. Accessed September 1, 2016."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1525-139X.2007.00311.x","article-title":"Hepatitis C virus infection and the dialysis patient","volume":"20","author":"Fabrizi","year":"2007","unstructured":"17. Fabrizi F, Lunghi G, Ganeshan V, Martin P, Messa P. Hepatitis C virus infection and the dialysis patient. Semin Dial 2007; 20:416-22.","journal-title":"Semin Dial"},{"key":"ref17","unstructured":"7. Central Narcotics Bureau, Singapore. Drug situation report 2016. Available at: https:\/\/www.cnb.gov.sg\/drugsituationreport\/drugsituationreport2016.aspx. Accessed September 16, 2016."},{"key":"ref18","first-page":"504","article-title":"Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore.","volume":"48","author":"Winslow","year":"2007","unstructured":"19. Winslow M, Subramaniam M, Ng WL, et al. Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore. Singapore Med J 2007; 48:504-8.","journal-title":"Singapore Med J","ISSN":"https:\/\/id.crossref.org\/issn\/0037-5675","issn-type":"print"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.meegid.2004.08.001","article-title":"The hepatitis C virus epidemic among injecting drug users","volume":"5","author":"Pybus","year":"2005","unstructured":"20. Pybus OG, Cochrane A, Holmes EC, Simmonds P. The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol 2005; 5:131-9.","journal-title":"Infect Genet Evol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"17410","DOI":"10.1038\/srep17410","article-title":"Peginterferon plus ribavirin for HIV-infected patients with treatment-na\u00efve acute or chronic HCV infection in Taiwan: a prospective cohort study","volume":"5","author":"Liu","year":"2015","unstructured":"21. Liu CH, Sheng WH, Sun HY, et al. Peginterferon plus ribavirin for HIV-infected patients with treatment-na\u00efve acute or chronic HCV infection in Taiwan: a prospective cohort study. Sci Rep 2015; 5:17410.","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.3748\/wjg.14.3416","article-title":"Treatment responses in Asians and Caucasians with chronic hepatitis C infection","volume":"14","author":"Yan","year":"2008","unstructured":"22. Yan KK, Guirgis M, Dinh T, et al. Treatment responses in Asians and Caucasians with chronic hepatitis C infection. World J Gastroenterol 2008; 14:3416-20.","journal-title":"World J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","unstructured":"23. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461:798-801.","journal-title":"Nature"},{"key":"ref23","first-page":"208","article-title":"Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism.","volume":"5","author":"Ekstrom","year":"2017","unstructured":"24. Ekstrom V, Kumar R, Zhao Y, et al. Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism. Gastroenterol Rep (Oxf) 2017; 5:208-12.","journal-title":"Gastroenterol Rep (Oxf )","ISSN":"https:\/\/id.crossref.org\/issn\/2052-0034","issn-type":"print"}],"container-title":["Singapore Medical Journal"],"original-title":[],"link":[{"URL":"http:\/\/www.smj.org.sg\/article\/prevalence-hepatitis-c-virus-infection-and-il28b-genotype-polymorphism-among-blood-donors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T10:49:29Z","timestamp":1660042169000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.smj.org.sg\/article\/prevalence-hepatitis-c-virus-infection-and-il28b-genotype-polymorphism-among-blood-donors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]},"published-print":{"date-parts":[[2019,1]]}},"URL":"https:\/\/doi.org\/10.11622\/smedj.2018078","relation":{},"ISSN":["0037-5675"],"issn-type":[{"value":"0037-5675","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}